Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wickham

Showing results (181-190 of 203) with videos related to

Pageof 21
Sort By:
Journal of Virology|February 14, 2004
Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responsesStefan Worgall, Annette Busch, Michael Rivara, et al.
Leukemia|April 30, 2004
The histone deacetylase inhibitor MS-275 induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia cellsD M Lucas, M E Davis, M R Parthun, et al.
Human Gene Therapy|October 25, 2002
Selective gene transfer into primary human gastric tumors using epithelial cell adhesion molecule-targeted adenoviral vectors with ablated native tropismDaniëlle A M Heideman, Victor W van Beusechem, G Johan A Offerhaus, et al.
Journal of Virology|February 28, 2002
Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolishedVictor W van Beusechem, Jacques Grill, D C Jeroen Mastenbroek, et al.
Molecular Cancer Therapeutics|July 12, 2015
Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302)Elena Geretti, Shannon Curtis Leonard, Nancy Dumont, et al.
Frontiers in Synaptic Neuroscience|October 30, 2018
Social Stimulus Causes Aberrant Activation of the Medial Prefrontal Cortex in a Mouse Model With Autism-Like BehaviorsAntonella Pirone, Jonathan M Alexander, Jenny B Koenig, et al.
Journal of Agricultural and Food Chemistry|April 18, 2008
Release of protein, lipid, and vitamin E from almond seeds during digestionGiuseppina Mandalari, Richard M Faulks, Gillian T Rich, et al.
Human Gene Therapy|January 1, 1997
Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotypeC A Mack, W R Song, H Carpenter, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 18, 2019
Nanoliposome targeting in breast cancer is influenced by the tumor microenvironmentNancy Dumont, Samantha Merrigan, Jason Turpin, et al.
British Journal of Cancer|October 27, 2018
Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation studyPamela Munster, Ian E Krop, Patricia LoRusso, et al.
Pageof 21

Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
Journal of Virology|February 14, 2004
Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responsesStefan Worgall, Annette Busch, Michael Rivara, et al.
Leukemia|April 30, 2004
The histone deacetylase inhibitor MS-275 induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia cellsD M Lucas, M E Davis, M R Parthun, et al.
Human Gene Therapy|October 25, 2002
Selective gene transfer into primary human gastric tumors using epithelial cell adhesion molecule-targeted adenoviral vectors with ablated native tropismDaniëlle A M Heideman, Victor W van Beusechem, G Johan A Offerhaus, et al.
Journal of Virology|February 28, 2002
Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolishedVictor W van Beusechem, Jacques Grill, D C Jeroen Mastenbroek, et al.
Molecular Cancer Therapeutics|July 12, 2015
Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302)Elena Geretti, Shannon Curtis Leonard, Nancy Dumont, et al.
Frontiers in Synaptic Neuroscience|October 30, 2018
Social Stimulus Causes Aberrant Activation of the Medial Prefrontal Cortex in a Mouse Model With Autism-Like BehaviorsAntonella Pirone, Jonathan M Alexander, Jenny B Koenig, et al.
Journal of Agricultural and Food Chemistry|April 18, 2008
Release of protein, lipid, and vitamin E from almond seeds during digestionGiuseppina Mandalari, Richard M Faulks, Gillian T Rich, et al.
Human Gene Therapy|January 1, 1997
Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotypeC A Mack, W R Song, H Carpenter, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 18, 2019
Nanoliposome targeting in breast cancer is influenced by the tumor microenvironmentNancy Dumont, Samantha Merrigan, Jason Turpin, et al.
British Journal of Cancer|October 27, 2018
Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation studyPamela Munster, Ian E Krop, Patricia LoRusso, et al.
Pageof 21